Department of Pathology, Kanto Medical Center NTT EC, Tokyo, Japan.
Pathol Int. 2010 Mar;60(3):222-7. doi: 10.1111/j.1440-1827.2009.02505.x.
Amyloidosis in non-Hodgkin's lymphoma (NHL) is known to be of the AL type, and AA-type amyloidosis in NHL is extremely rare. Herein is reported an autopsy case of follicular lymphoma that transformed to diffuse large B-cell lymphoma (DLBCL) in a relapse associated with systemic AA amyloidosis. CMV infection in an immunocompromised state with chemotherapy against DLBCL may have been involved in amyloid accumulation. The serum amyloid A (SAA)1 gene polymorphism, SAA1.2/1.3, might have also been another factor in this case, considering the risk of AA amyloidosis in Japanese patients with rheumatoid arthritis.
非霍奇金淋巴瘤(NHL)中的淀粉样变性已知为 AL 型,而 NHL 中的 AA 型淀粉样变性极为罕见。本文报道了一例滤泡淋巴瘤病例,该患者在复发时发生弥漫性大 B 细胞淋巴瘤(DLBCL)转化,并伴有系统性 AA 淀粉样变性。DLBCL 化疗导致的免疫功能低下合并 CMV 感染可能与淀粉样物质的积累有关。考虑到日本类风湿关节炎患者发生 AA 淀粉样变性的风险,血清淀粉样蛋白 A(SAA)1 基因多态性 SAA1.2/1.3 也可能是该病例的另一个因素。